Literature DB >> 15668540

Atazanavir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failures.

Margaret Johnson, Beatriz Grinsztejn, Claudia Rodriguez, Jeffrey Coco, Edwin DeJesus, Adriano Lazzarin, Kenneth Lichtenstein, Anna Rightmire, Serap Sankoh, Richard Wilber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15668540     DOI： 10.1097/00002030-200501280-00007

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  6 in total

1.  Incidence of hyperbilirubinemia and jaundice due to atazanavir in a cohort of Hispanic patients.

Authors:  Emiliano Bissio; Gustavo D Lopardo
Journal:  AIDS Res Hum Retroviruses       Date:  2012-11-28       Impact factor: 2.205

2.  Long-term safety and efficacy of atazanavir-based therapy in HIV-infected infants, children and adolescents: the Pediatric AIDS Clinical Trials Group Protocol 1020A.

Authors:  Richard M Rutstein; Pearl Samson; Terry Fenton; Courtney V Fletcher; Jennifer J Kiser; Lynne M Mofenson; Elizabeth Smith; Bobbie Graham; Marina Mathew; Grace Aldrovani
Journal:  Pediatr Infect Dis J       Date:  2015-02       Impact factor: 2.129

Review 3.  Efficacy and safety of once-daily regimens in the treatment of HIV infection.

Authors:  Jean-Michel Molina
Journal:  Drugs       Date:  2008       Impact factor: 9.546

4.  Short communication: fasting increases serum concentrations of bilirubin in patients receiving atazanavir: results from a pilot study.

Authors:  Gustavo Lopardo; Emiliano Bissio; Lidia Espinola; Paula Gallego; Marcela Stambullian; Adrián Gadano
Journal:  AIDS Res Hum Retroviruses       Date:  2012-10-31       Impact factor: 2.205

5.  Incidence of atazanavir- associated adverse drug reactions in second -line drugs treated south Indian HIV-1 infected patients.

Authors:  Dhakshinamoorthy Subashini; Thongadi Ramesh Dinesha; Jayaseelan Boobalan; Lawrence Christopher Samuel; Selvamuthu Poongulali; Ambrose Pradeep; Sunil Suhas Solomon; Suniti Solomon; Pachamuthu Balakrishnan; Shanmugam Saravanan
Journal:  Indian J Pharmacol       Date:  2016 Sep-Oct       Impact factor: 1.200

6.  Cost-Effectiveness of Single- Versus Generic Multiple-Tablet Regimens for Treatment of HIV-1 Infection in the United States.

Authors:  Donna E Sweet; Frederick L Altice; Calvin J Cohen; Björn Vandewalle
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.